Literature DB >> 28887216

Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: A review.

Zhaoyi Wang1, Qing Xia2, Xin Liu1, Wenxue Liu1, Wanzhen Huang1, Xue Mei1, Jun Luo1, Mingxu Shan1, Ruichao Lin3, Dixin Zou4, Zhiqiang Ma5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Forsythiae Fructus (called Lianqiao in Chinese), the fruit of Forsythia suspensa (Thunb.) Vahl, is utilized as a common traditional medicine in China, Japan and Korea. It is traditionally used to treat pyrexia, inflammation, gonorrhea, carbuncle and erysipelas. Depending on the different harvest time, Forsythiae Fructus can be classified into two forms, namely Qingqiao and Laoqiao. The greenish fruits that start to ripen are collected as Qingqiao, while the yellow fruits that are fully ripe are collected as Laoqiao. Both are applied to medical use. This review aims to provide a systematic summary of F. suspensa (Forsythia suspensa (Thunb.) Vahl) and to reveal the correlation between the traditional uses and pharmacological activities so as to offer inspiration for future research.
MATERIALS AND METHODS: All corresponding information about F. suspensa was searched by Scifinder and obtained from scientific databases including Springer, Science Direct, Wiley, Pubmed and China Knowledge Resource Integrated (CNKI). Local dissertations and books were searched as well.
RESULTS: According to classical Chinese herbal texts and Chinese Pharmacopoeia, Forsythiae Fructus dominantly displays heat-clearing and detoxifying effects in TCM prescriptions. In modern research, more than 230 compounds were separated and identified from F. suspensa. 211 Of them were isolated from fruits. Lignans and phenylethanoid glycosides are considered as the characteristic and active constituents of this herb, such as forsythiaside, phillyrin, rutin and phillygenin. They exhibited anti-inflammatory, antioxidant, antibacterial, anti-virus, anti-cancer and anti-allergy effects, etc. Currently, there is no report on the toxicity of Forsythiae Fructus, despite slight toxicity of forsythiaside reported in local publications. Compared to Laoqiao, Qingqiao contains higher levels of forsythiaside, forsythoside C, cornoside, rutin, phillyrin, gallic acid and chlorogenic acid and lower levels of rengyol, β-glucose and S-suspensaside methyl ether.
CONCLUSION: Heat-clearing actions of Forsythiae Fructus are based on the anti-inflammatory and antioxidant properties of lignans and phenylethanoid glycosides. Detoxifying effects attribute to the antibacterial, antiviral and anti-cancer activities of Forsythiae Fructus. And traditional Chinese medicine (TCM) characteristics of Forsythiae Fructus (bitter flavor, slightly cold nature and lung meridian) supported its strong anti-inflammatory effects. In addition, the remarkable anti-inflammatory and antioxidant capacities of Forsythiae Fructus contribute to its anti-cancer and neuroprotective activities. The higher proportion of lignans and phenylethanoid glycosides in Qingqiao than Laoqiao might explain the better antioxidant ability of Qingqiao and more frequent uses of Qingqiao in TCM prescriptions. For future research, more in vivo experiments and clinical studies are encouraged to further clarify the relation between traditional uses and modern applications. Regarding to Qingqiao and Laoqiao, they remain to be differentiated by all-round quality control methods, and the chemical compositions and clinical effects between them should be compared.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Forsythia suspensa (Thunb.) Vahl; Pharmacology; Phytochemistry; Quality control; Traditional uses

Mesh:

Substances:

Year:  2017        PMID: 28887216     DOI: 10.1016/j.jep.2017.08.040

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  48 in total

1.  Comparative transcriptome analyses of three medicinal Forsythia species and prediction of candidate genes involved in secondary metabolisms.

Authors:  Luchao Sun; Amit Rai; Megha Rai; Michimi Nakamura; Noriaki Kawano; Kayo Yoshimatsu; Hideyuki Suzuki; Nobuo Kawahara; Kazuki Saito; Mami Yamazaki
Journal:  J Nat Med       Date:  2018-05-07       Impact factor: 2.343

2.  Comparative transcriptome analyses identify genes involved into the biosynthesis of forsythin and forsythoside A in Forsythia suspensa.

Authors:  Wang Jun Yuan; Su Ping Zhang; Zhi Yin He; Yan Xia He; She Qi He; Li Jun Liu; Xin Sun; Qin Li
Journal:  Funct Integr Genomics       Date:  2022-07-23       Impact factor: 3.674

3.  Phillyrin Prevents Ovariectomy-Induced Osteolysis by Inhibiting Osteoclast Differentiation.

Authors:  Geng Zhang; Ying Zhang; Cong Wang; Chenhe Zhou; Shigui Yan
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-10       Impact factor: 2.650

4.  A Discovery Strategy for Active Compounds of Chinese Medicine Based on the Prediction Model of Compound-Disease Relationship.

Authors:  Mengqi Huo; Sha Peng; Jing Li; Yanling Zhang; Yanjiang Qiao
Journal:  J Oncol       Date:  2022-07-08       Impact factor: 4.501

Review 5.  Review on the Pharmacological Properties of Phillyrin.

Authors:  Chenyu Zhou; Mengya Lu; Jialei Cheng; Emelda Rosseleena Rohani; Hamizah Shahirah Hamezah; Rongchun Han; Xiaohui Tong
Journal:  Molecules       Date:  2022-06-07       Impact factor: 4.927

Review 6.  Arbuscular mycorrhizal fungi and production of secondary metabolites in medicinal plants.

Authors:  YanYan Zhao; Annalisa Cartabia; Ismahen Lalaymia; Stéphane Declerck
Journal:  Mycorrhiza       Date:  2022-05-13       Impact factor: 3.856

7.  Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?

Authors:  Zhenjie Zhuang; Junmao Wen; Lu Zhang; Mingjia Zhang; Xiaoying Zhong; Huiqi Chen; Chuanjin Luo
Journal:  Eur J Integr Med       Date:  2020-05-26       Impact factor: 1.314

8.  Genetic Toxicology and Safety Pharmacological Evaluation of Forsythin.

Authors:  Zhong Han; Jianmin Guo; Feibiao Meng; Haifeng Liao; Yinghua Deng; Yuankeng Huang; Xialing Lei; Chun Liang; Richou Han; Wei Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-18       Impact factor: 2.629

9.  Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.

Authors:  Ying Sun; Yu-Jun Tan; Zhan-Zhao Lu; Bing-Bing Li; Cheng-Hong Sun; Tao Li; Li-Li Zhao; Zhong Liu; Gui-Min Zhang; Jing-Chun Yao; Jie Li
Journal:  Front Pharmacol       Date:  2018-03-27       Impact factor: 5.810

10.  COVID-19: Fear, quackery, false representations and the law.

Authors:  Ian Freckelton Qc
Journal:  Int J Law Psychiatry       Date:  2020-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.